These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10084469)

  • 41. Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.
    Turner MO; Johnston PR; Pizzichini E; Pizzichini MM; Hussack PA; Hargreave FE
    Can Respir J; 1998; 5(4):261-8. PubMed ID: 9753527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care. UK Study Group.
    Jones KP
    Thorax; 1994 Oct; 49(10):971-5. PubMed ID: 7974313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac side effects of long-acting beta-2 agonist salmeterol in asthmatic children.
    Tunaoğlu FS; Türktaş I; Olguntürk R; Demirsoy S
    Pediatr Int; 1999 Feb; 41(1):28-31. PubMed ID: 10200132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.
    Lundback B; Rawlinson DW; Palmer JB
    Thorax; 1993 Feb; 48(2):148-53. PubMed ID: 8493629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and Holter monitoring.
    Kemp JP; Bierman CW; Cocchetto DM
    Ann Allergy; 1993 Apr; 70(4):316-22. PubMed ID: 8466097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Salmeterol compared with current therapies in chronic asthma.
    Adinoff AD; Schwartz HJ; Rickard KA; Yancey SW; Swearingen BE
    J Fam Pract; 1998 Oct; 47(4):278-84. PubMed ID: 9789513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma.
    Newhouse MT; Chapman KR; McCallum AL; Abboud RT; Bowie DM; Hodder RV; Paré PD; Mesic-Fuchs H; Molfino NA
    Chest; 1996 Sep; 110(3):595-603. PubMed ID: 8797398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the effects of salmeterol and formoterol in patients with severe asthma.
    Nightingale JA; Rogers DF; Barnes PJ
    Chest; 2002 May; 121(5):1401-6. PubMed ID: 12006420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of salmeterol xinafoate in the treatment of COPD.
    Mahler DA; Donohue JF; Barbee RA; Goldman MD; Gross NJ; Wisniewski ME; Yancey SW; Zakes BA; Rickard KA; Anderson WH
    Chest; 1999 Apr; 115(4):957-65. PubMed ID: 10208192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
    Lipworth BJ; Dempsey OJ; Aziz I
    Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia.
    Cazzola M; Imperatore F; Salzillo A; Di Perna F; Calderaro F; Imperatore A; Matera MG
    Chest; 1998 Aug; 114(2):411-5. PubMed ID: 9726723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD.
    O'Donnell DE; Sciurba F; Celli B; Mahler DA; Webb KA; Kalberg CJ; Knobil K
    Chest; 2006 Sep; 130(3):647-56. PubMed ID: 16963658
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled corticosteroids.
    Lai CK; Chan CH; Ho SS; Hui AC; Lai KN
    Chest; 1995 Jul; 108(1):36-40. PubMed ID: 7606988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Appleton S; Smith B; Veale A; Bara A
    Cochrane Database Syst Rev; 2000; (2):CD001104. PubMed ID: 10796594
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
    Baraniuk J; Murray JJ; Nathan RA; Berger WE; Johnson M; Edwards LD; Srebro S; Rickard KA
    Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.